This site uses cookies to improve your browsing experience. we’ll assume you’re OK to continue. If you want to read more about this, please chick
PRIVACY
,thank you.
×
United Biomedical Inc.
About
About UBI
Founder, Chairperson and CEO's message
Leadership team
Pipeline
Technology
High precision vaccines employing UBITh design platform
mAb Development Platforms
Long acting protein drug developement platform
Manufacturing Capabilities
News
Publications
Media coverage
Locations
Video
UB-612 Universal Vaccine
Monoclonal antibody
Contact
Video
HOME
Video
Monoclonal antibody
Please select a type
UB-612 Universal Vaccine
Monoclonal antibody
VIDEO
IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE-downregulation and relieves urticaria symptoms
IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE-downregulation and relieves urticaria symptoms
Contact
HOME
About
About UBI
Founder, Chairperson and CEO's message
Leadership team
Pipeline
Technology
High precision vaccines employing UBITh design platform
mAb Development Platforms
Long acting protein drug developement platform
Manufacturing Capabilities
News
Publications
Media coverage
Locations
Video
UB-612 Universal Vaccine
Monoclonal antibody
Contact